{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T21:53:54Z","timestamp":1759960434061},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1996,4,1]],"date-time":"1996-04-01T00:00:00Z","timestamp":828316800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1996,4]]},"DOI":"10.1007\/bf02247441","type":"journal-article","created":{"date-parts":[[2005,11,15]],"date-time":"2005-11-15T14:18:32Z","timestamp":1132064312000},"page":"355-364","source":"Crossref","is-referenced-by-count":39,"title":["Ethological analysis of cholecystokinin (CCKA and CCKB) receptor ligands in the elevated plus-maze test of anxiety in mice"],"prefix":"10.1007","volume":"124","author":[{"given":"N. J. T.","family":"Johnson","sequence":"first","affiliation":[]},{"given":"R. J.","family":"Rodgers","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"BF02247441_CR1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0006-3223(94)91187-8","volume":"36","author":"JL Abelson","year":"1994","unstructured":"Abelson JL, Nesse RM (1994) Pentagastrin infusions in patients with panic disorder. 1.Symptoms and cardiovascular responses. Biol Psychiatry 36:73\u201383","journal-title":"Biol Psychiatry"},{"key":"BF02247441_CR2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0031-9384(93)90050-P","volume":"54","author":"RE Adamec","year":"1993","unstructured":"Adamec RE, Shallow T (1993) Lasting effects on rodent anxiety of a single exposure to a cat. Physiol Behav 54:101\u2013109","journal-title":"Physiol Behav"},{"key":"BF02247441_CR3","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0014-2999(94)90800-1","volume":"271","author":"MJ Bickerdike","year":"1994","unstructured":"Bickerdike MJ, Marsden CA, Dourish CT, Fletcher A (1994) The influence of 5-hydroxytryptamine reuptake blockade on CCK receptor antagonist effects in the rat elevated zero-maze. Eur J Pharmacol 271:403\u2013411","journal-title":"Eur J Pharmacol"},{"key":"BF02247441_CR4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/070674379003500115","volume":"35","author":"J Bradwejn","year":"1990","unstructured":"Bradwejn J, Koszycki D, Meterissian G (1990) Cholecystokinintetrapeptide induces panic attacks in patients with panic disorder. Can J Psychiatry 35:83\u201385","journal-title":"Can J Psychiatry"},{"key":"BF02247441_CR5","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/archpsyc.1991.01810310021005","volume":"48","author":"J Bradwejn","year":"1991","unstructured":"Bradwejn J, Koszycki D, Shriqui C (1991) Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder \u2014 clinical and behavioral findings. Arch Gen Psychiatry 48:603\u2013610","journal-title":"Arch Gen Psychiatry"},{"key":"BF02247441_CR6","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1177\/026988119200600301","volume":"6","author":"J Bradwejn","year":"1992","unstructured":"Bradwejn J, Koszycki D, Couetoux du Tertre A, Bourin M, Palmour RM, Ervin FR (1992) The cholecystokinin hypothesis of panic and anxiety disorders: a review. J Psychopharmacol 6:345\u2013351","journal-title":"J Psychopharmacol"},{"key":"BF02247441_CR7","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/archpsyc.1994.03950060050005","volume":"51","author":"J Bradwejn","year":"1994","unstructured":"Bradwejn J, Koszycki D, Dutertre AC Vanmegen H, Denboer J, Westenberg H, Annable L (1994) The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder. Arch Gen Psychiatry 51:486\u2013493","journal-title":"Arch Gen Psychiatry"},{"key":"BF02247441_CR8","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/BF02244646","volume":"110","author":"P Chopin","year":"1993","unstructured":"Chopin P, Briley M (1993) The benzodiazepine antagonist flumazenil blocks the effects of CCK receptor agonists and antagonists in the elevated plus-maze. Psychopharmacology 110:409\u2013414","journal-title":"Psychopharmacology"},{"key":"BF02247441_CR9","first-page":"573","volume":"4","author":"JC Cole","year":"1993","unstructured":"Cole JC, Rodgers RJ (1993) An ethological analysis of the effects of chlordiazepoxide and bretazenil (Ro 16-6028) in the murine elevated plus-maze. Behav Pharmacol 4:573\u2013580","journal-title":"Behav Pharmacol"},{"key":"BF02247441_CR10","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/BF02244851","volume":"114","author":"JC Cole","year":"1994","unstructured":"Cole JC, Rodgers RJ (1994) Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test \u2014 comparison with haloperidol. Psychopharmacology 114:288\u2013296","journal-title":"Psychopharmacology"},{"key":"BF02247441_CR11","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0091-3057(95)00163-Q","volume":"52","author":"JC Cole","year":"1995","unstructured":"Cole JC, Rodgers RJ (1995) Ethological comparison of the effects of diazepam and acute\/chronic imipramine on the behaviour of mice in the elevated plus-maze. Pharmacol Biochem Behav 52:473\u2013478","journal-title":"Pharmacol Biochem Behav"},{"key":"BF02247441_CR12","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/BF02245943","volume":"118","author":"JC Cole","year":"1995","unstructured":"Cole, JC, Burroughs, GJ, Laverty, CR, Sherriff, NC, Sparham, EA, Rodgers RJ (1995) Anxiolytic-like effects of yohimbine in the murine plus-maze: strain independence and evidence against \u03b12-adrenoceptor mediation. Psychopharmacology 118:425\u2013436","journal-title":"Psychopharmacology"},{"key":"BF02247441_CR13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0143-4179(91)90084-V","volume":"19","author":"B Costall","year":"1991","unstructured":"Costall B, Domeney AM, Hughes J, Kelly ME, Naylor RJ, Woodruff GN (1991) Anxiolytic effects of CCK-B antagonists. Neuropeptides 19:65\u201373","journal-title":"Neuropeptides"},{"key":"BF02247441_CR14","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0196-9781(94)90104-X","volume":"15","author":"JN Crawley","year":"1994","unstructured":"Crawley JN, Corwin RL (1994) Biological actions of cholecystokinin. Peptides 15:731\u2013755","journal-title":"Peptides"},{"key":"BF02247441_CR15","first-page":"680","volume":"35","author":"NR Cutler","year":"1994","unstructured":"Cutler NR, Sramek JJ, Kramer MS, Reines SA (1994) Placebo-controlled study of a CCKB antagonist in patents with panic disorder. Biol Psychiatry 35:680","journal-title":"Biol Psychiatry"},{"key":"BF02247441_CR16","first-page":"531","volume":"47","author":"V Dauge","year":"1992","unstructured":"Dauge V, Derrien M, Durieux C, Noble F, Corringer PJ, Roques BP (1992) Effects of selective agonists for cholecystokinin receptors CCK-B in nociception and behavior in rodents. Therapie 47:531\u2013539","journal-title":"Therapie"},{"key":"BF02247441_CR17","unstructured":"Dawson GR, Rupniak NMJ, Iversen SD, Tricklebank MD (1994) Lack of effect of CCKB receptor antagonists in animal screens for anxiolytic drugs. J Psychopharmacol 8:A47"},{"key":"BF02247441_CR18","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1001\/archpsyc.1989.01810060031006","volume":"46","author":"C DeMontigny","year":"1989","unstructured":"DeMontigny C (1989) Cholecystokinin tetrapeptide induces panic-like attacks in healthy-volunteers \u2014 preliminary findings. Arch Gen Psychiatry 46:511\u2013517","journal-title":"Arch Gen Psychiatry"},{"key":"BF02247441_CR19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0006-8993(93)91084-6","volume":"617","author":"M Derrien","year":"1993","unstructured":"Derrien M, Durieux C, Dauge V, Roques BP (1993) Involvement of D(2) dopaminergic receptors in the emotional and motivational responses induced by injection of CCK-8 in the posterior part of the rat nucleus-accumbens. Brain Res 617:181\u2013188","journal-title":"Brain Res"},{"key":"BF02247441_CR20","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0091-3057(94)90467-7","volume":"49","author":"M Derrien","year":"1994","unstructured":"Derrien M, McCort-Tranchepain I, Ducos B, Roques BP, Durieux C (1994) Heterogeneity of CCK-B receptors involved in animal-models of anxiety. Pharmacol Biochem Behav 49:133\u2013141","journal-title":"Pharmacol Biochem Behav"},{"key":"BF02247441_CR21","first-page":"29","volume":"5","author":"CT Dourish","year":"1994","unstructured":"Dourish CT, Bickerdike MJ, Stanhope KJ, Fletcher A, Marsden CT (1994) Profile of CCKA and CCKB receptor antagonists in the CER end elevated plus-maze models of anxiety in the rat: modulation by 5-HT reuptake blockade. Behav Pharmacol 5:29\u201330","journal-title":"Behav Pharmacol"},{"key":"BF02247441_CR22","unstructured":"Ervin FR, Palmour RM, Bradwejn J (1991) A new primate model for panic disorder. Biol Psychiatry 29:430S"},{"key":"BF02247441_CR23","first-page":"30","volume":"5","author":"H Fink","year":"1994","unstructured":"Fink H, Rex A, Marsden CA (1994) Behavioural and neurochemical effects of CCK-fragments in animal models of anxiety. Behav Pharmacol 5:30","journal-title":"Behav Pharmacol"},{"key":"BF02247441_CR24","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0149-7634(05)80134-4","volume":"15","author":"J Harro","year":"1991","unstructured":"Harro J, Vasar E (1991a) Cholecystokinin-induced anxiety \u2014 how is it reflected in studies on exploratory-behavior? Neurosci Biobehav Rev 15:473\u2013477","journal-title":"Neurosci Biobehav Rev"},{"key":"BF02247441_CR25","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0014-2999(91)90156-K","volume":"193","author":"J Harro","year":"1991","unstructured":"Harro J, Vasar E (1991b) Evidence that CCKB receptors mediate the regulation of exploratory behavior in the rat. Eur J Pharmacol 193:379\u2013381","journal-title":"Eur J Pharmacol"},{"key":"BF02247441_CR26","first-page":"62","volume":"341","author":"J Harro","year":"1990","unstructured":"Harro J, Pold M, Vasar E (1990) Anxiogenic-like action of cerulein, a CCK-8 receptor agonist, in the mouse-influence of acute and subchronic diazepam treatment. Naunyn-Schmiedeberg's Arch Pharmacol 341:62\u201367","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"BF02247441_CR27","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0165-6147(93)90020-K","volume":"14","author":"J Harro","year":"1993","unstructured":"Harro J, Vasar E, Bradwejn J (1993) CCK in animal and human research on anxiety. Trends Pharmacol Sci 14:244\u2013249","journal-title":"Trends Pharmacol Sci"},{"key":"BF02247441_CR28","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0143-4179(80)90009-8","volume":"1","author":"SE Hays","year":"1980","unstructured":"Hays SE, Beinfeld MC, Jensen RT, Goodwin FK, Paul SM (1980) Demonstration of a putative receptor site for cholecystokinin in the rat brain. Neuropeptides 1:53\u201362","journal-title":"Neuropeptides"},{"key":"BF02247441_CR29","unstructured":"Hendrie CA, Dourish CT (1993) Effects of cholecystokinin tetrapeptide (CCK-4) and the CCKB antagonist LY-288513 in a putative model of panic in the mouse. Br J Pharmacol 108:26P"},{"key":"BF02247441_CR30","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/oso\/9780198577560.003.0012","volume-title":"Multiple cholecystokinin receptors in the CNS","author":"CA Hendrie","year":"1992","unstructured":"Hendrie CA, Neill JC (1992) Ethological analysis of the role of CCK in anxiety. In: Dourish CT, Cooper SJ, Iversen SD, Iversen LL (eds) Multiple cholecystokinin receptors in the CNS. Oxford University Press, Oxford, pp 132\u2013142"},{"key":"BF02247441_CR31","doi-asserted-by":"crossref","first-page":"6728","DOI":"10.1073\/pnas.87.17.6728","volume":"87","author":"J Hughes","year":"1990","unstructured":"Hughes J, Boden P, Costall B et al. (1990) Development of a class of selective cholecystokinin type-B receptor antagonists having potent anxiolytic activity. Proc Natl Acad Sci USA 87:6728\u20136732","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02247441_CR32","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0014-2999(80)90221-6","volume":"65","author":"RB Innis","year":"1980","unstructured":"Innis RB, Snyder SH (1980) Cholecystokinin receptor binding in brain and pacreas: regulation of pancreatic binding by cyclic and acyclic guanine nucleotides. Eur J Pharmacol 65:123\u2013124","journal-title":"Eur J Pharmacol"},{"key":"BF02247441_CR33","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1152\/ajplegacy.1928.86.3.599","volume":"86","author":"AC Ivy","year":"1928","unstructured":"Ivy AC, Goldberg EA (1928) A hormone mechanism for gall bladder contraction and evacuation. Am J Physiol 86:599\u2013613","journal-title":"Am J Physiol"},{"key":"BF02247441_CR34","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1073\/pnas.77.4.2079","volume":"77","author":"RT Jensen","year":"1980","unstructured":"Jensen RT, Lemp GF, Gardner JD (1980) Interaction of cholecystokinin with specific membrane receptors on pancreatic acinae cells. Proc Natl Acad Sci USA 77:2079\u20132083","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02247441_CR35","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1748-1716.1966.tb03185.x","volume":"66","author":"JE Jorpes","year":"1966","unstructured":"Jorpes JE, Mutt V (1966) Cholecystokinin and pancreozymin, one single hormone? Acta Physiol Scand 66:196\u2013202","journal-title":"Acta Physiol Scand"},{"key":"BF02247441_CR36","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/npp.1993.81","volume":"9","author":"C Lines","year":"1993","unstructured":"Lines C, traub M, Ambrose J (1993) CCK and anxiety in normal volunteers. Neuropsychopharmacology 9:S 181\u2013182","journal-title":"Neuropsychopharmacology"},{"key":"BF02247441_CR37","first-page":"180","volume":"92","author":"RG Lister","year":"1987","unstructured":"Lister RG (1987) The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92:180\u2013185","journal-title":"Psychopharmacology"},{"key":"BF02247441_CR38","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/BF00169136","volume":"349","author":"PT Mannisto","year":"1994","unstructured":"Mannisto PT, Lang A, Harro J, Peuranen E, Bradwejn J, Vasar E (1994) Opposite effects mediated by CCKA and CCKB receptors in behavioral and hormonal studies in rats. Naunyn-Schmiedeberg's Arch Pharmacol 349:478\u2013484","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"BF02247441_CR39","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0006-8993(86)91413-7","volume":"362","author":"TH Moran","year":"1986","unstructured":"Moran TH, Robinson PH, Goldrich MS, Mchugh PR (1986) 2 brain cholecystokinin receptors \u2014 implications for behavioral actions. Brain Res 362:175\u2013179","journal-title":"Brain Res"},{"key":"BF02247441_CR40","first-page":"420.13","volume":"17","author":"JD Newman","year":"1991","unstructured":"Newman JD, Crepeau LJ (1991) Heart rate changes following administration of putative panicogenic chemicals in squirrel monkeys. Soc Neurosci Abstr 17:420.13","journal-title":"Soc Neurosci Abstr"},{"key":"BF02247441_CR41","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00001756-199312000-00009","volume":"5","author":"S Pavlasevic","year":"1993","unstructured":"Pavlasevic S, Bednar I, Qureshi GA, Sodersten P (1993) Brain cholecystokinin tetrapeptide levels are increased in a rat model of anxiety. Neuroreport 5:225\u2013228","journal-title":"Neuroreport"},{"key":"BF02247441_CR42","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0165-0270(85)90031-7","volume":"14","author":"S Pellow","year":"1985","unstructured":"Pellow S, Chopin P, File SE, Briley M (1985) Validation of openclosed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14:149\u2013169","journal-title":"J Neurosci Methods"},{"key":"BF02247441_CR43","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0006-8993(91)91139-R","volume":"548","author":"J Rataud","year":"1991","unstructured":"Rataud J, Darche F, Piot O, Stutzmann JM, Bohme GA, Blanchard JC (1991) Anxiolytic effect of CCK-Antagonists on plus-maze behavior in mice. Brain Res 548:315\u2013317","journal-title":"Brain Res"},{"key":"BF02247441_CR44","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0165-6147(90)90004-R","volume":"11","author":"S Ravard","year":"1990","unstructured":"Ravard S, Dourish CT (1990) Cholecystokinin and anxiety. Trends Pharmacol Sci 11:271\u2013273","journal-title":"Trends Pharmacol Sci"},{"key":"BF02247441_CR45","unstructured":"Ravard S, Dourish CT, Iversen SD (1990) Evidence that the anxiolytic-like effects of the CCK antagonists devazepide and L-365, 260 in the elevated plus-maze paradigm in rats are mediated by CCK receptors. Br J Pharmacol 101:576P"},{"key":"BF02247441_CR46","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/oso\/9780198577560.003.0010","volume-title":"Multiple cholecystokinin receptors in the CNS","author":"JF Rehfeld","year":"1992","unstructured":"Rehfeld JF (1992) CCK and anxiety: introduction. In: Dourish CT, Cooper SJ, Iversen SD, Iversen LL (eds) Multiple cholecystokinin receptors in the CNS. Oxford University Press, Oxford, pp 117\u2013120"},{"key":"BF02247441_CR47","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0304-3940(94)90681-5","volume":"172","author":"A Rex","year":"1994","unstructured":"Rex A, Barth T, Voigt JP, Domeney AM, Fink H (1994a) Effects of cholecystokinin tetrapeptide and sulfated cholecystokinin-octapeptide in rat models of anxiety. Neurosci Lett 172:139\u2013142","journal-title":"Neurosci Lett"},{"key":"BF02247441_CR48","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/0028-3908(94)90087-6","volume":"33","author":"A Rex","year":"1994","unstructured":"Rex A, Fink H, Marsden CA (1994b) Effects of BOC-CCK-4 and L365, 260 on cortical 5-HT release in guinea-pigs on exposure to the elevated plus-maze. Neuropharmacology 33:559\u2013565","journal-title":"Neuropharmacology"},{"key":"BF02247441_CR49","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0031-9384(93)90222-2","volume":"53","author":"RJ Rodgers","year":"1993","unstructured":"Rodgers RJ, Cole JC (1993) Anxitey enhancement in the murine elevated plus-maze by immediate prior exposure to social stressors. Physiol Behav 53:83\u2013388","journal-title":"Physiol Behav"},{"key":"BF02247441_CR50","first-page":"9","volume-title":"Ethology and Psychopharmacology","author":"RJ Rodgers","year":"1994","unstructured":"Rodgers RJ, Cole JC (1994a) The elevated plus-maze: pharmacology, methodology and ethology. In: Cooper SJ, Hendrie CA (eds) Ethology and Psychopharmacology. Wiley, Chichester, pp 9\u201344"},{"key":"BF02247441_CR51","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0014-2999(94)90124-4","volume":"261","author":"RJ Rodgers","year":"1994","unstructured":"Rodgers RJ, Cole JC (1994b) Anxiolytic-like effect of (s)-WAY-100135, a 5-HT1A receptor antagonist, in the murine elevated plus-maze test. Eur J Pharmacol 261:321\u2013325","journal-title":"Eur J Pharmacol"},{"key":"BF02247441_CR52","unstructured":"Rodgers RJ, Johnson NJT (1995a) Cholecystokinin and anxiety: promises and pitfalls. Crit Rev Neurobio (in press)"},{"key":"BF02247441_CR53","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0091-3057(95)00138-M","volume":"52","author":"RJ Rodgers","year":"1995","unstructured":"Rodgers RJ, Johnson NJT (1995b) Factor analysis of the spatiotemporal and ethological measures in the murine elevated plus-maze. Pharmacol Biochem Behav 52:297\u2013303","journal-title":"Pharmacol Biochem Behav"},{"key":"BF02247441_CR54","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF02245704","volume":"113","author":"RJ Rodgers","year":"1993","unstructured":"Rodgers RJ, Shepherd JK (1993) Influence of prior maze experience on behaviour and response to diazepam in the elevated plus-maze and light\/dark tests of anxiety in mice. Psychopharmacology 113:237\u2013242","journal-title":"Psychopharmacology"},{"key":"BF02247441_CR55","first-page":"621","volume":"3","author":"RJ Rodgers","year":"1992","unstructured":"Rodgers RJ, Cole JC, Cobain MR, Daly P, Doran PJ, Eells JR, Wallis P (1992a) Anxiogenic-like effects of fluprazine and eltoprazine in the mouse elevated plus-maze \u2014 profile comparisons with 8-OH-DPAT, CGS 12066B, TFMPP and mCPP. Behav Pharmacol 3:621\u2013634","journal-title":"Behav Pharmacol"},{"key":"BF02247441_CR56","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/BF02253596","volume":"106","author":"RJ Rodgers","year":"1992","unstructured":"Rodgers RJ, Lee C, Shepherd JK (1992b) Effects of diazepam on behavioural and antinociceptive responses to the elevated plusmaze in male mice depend upon treatment regimen and prior maze experience. Psychopharmacology 106:102\u2013110","journal-title":"Psychopharmacology"},{"key":"BF02247441_CR57","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0091-3057(94)90205-4","volume":"48","author":"RJ Rodgers","year":"1994","unstructured":"Rodgers RJ, Cole JC, Davies A (1994a) Antianxiety and behavioral suppressant actions of the novel 5-HT1A receptor agonist, flesinoxan. Pharmacol Biochem Behav 48:959\u2013963","journal-title":"Pharmacol Biochem Behav"},{"key":"BF02247441_CR58","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/0091-3057(94)90253-4","volume":"49","author":"RJ Rodgers","year":"1994","unstructured":"Rodgers RJ, Nikulina EM, Cole JC (1994b) Dopamine D-1 and D-2 receptor ligands modulate the behavior of mice in the elevated plus-maze. Pharmacol Biochem Behav 49:985\u2013995","journal-title":"Pharmacol Biochem Behav"},{"key":"BF02247441_CR59","doi-asserted-by":"crossref","unstructured":"Rodgers RJ, Cole JC, Aboualfa K, Stephenson LH (1995) Ethopharmacological analysis of the effects of putative \u201canxiogenic\u201d agents in the mouse elevated plus-maze. Pharmacol Biochem Behav 52 (in press)","DOI":"10.1016\/0091-3057(95)00190-8"},{"key":"BF02247441_CR60","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0143-4179(93)90090-W","volume":"25","author":"NMJ Rupniak","year":"1993","unstructured":"Rupniak NMJ, Schaffer L, Siegl P, Iversen SD (1993) Failure of intravenous pentagastrin challenge to induce panic-like effects in rhesus-monkeys. Neuropeptides 25:115\u2013119","journal-title":"Neuropeptides"},{"key":"BF02247441_CR61","first-page":"433","volume":"37","author":"A Saito","year":"1980","unstructured":"Saito A, Goldfine ID, Williams JA (1980) Characterization of receptors for cholecystokinin and related peptides in mouse cerebral cortex. J Neurochem 37:433\u2013490","journal-title":"J Neurochem"},{"key":"BF02247441_CR62","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0003-2697(83)90089-1","volume":"133","author":"A Sauter","year":"1983","unstructured":"Sauter A, Frick W (1983) Determination of cholecystokinin tetrapeptide and cholecystokinin octapeptide sulfate in different rat-brain regions by high-pressure liquid-chromatography with electrochemical detection. Anal Biochem 133:307\u2013313","journal-title":"Anal Biochem"},{"key":"BF02247441_CR63","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/BF02244871","volume":"116","author":"JK Shepherd","year":"1994","unstructured":"Shepherd JK, Grewal SS, Fletcher A, Bill DJ, Dourish CT (1994) Behavioral and pharmacological characterization of the elevated zero-maze as an animal-model of anxiety. Psychopharmacology 116:56\u201364","journal-title":"Psychopharmacology"},{"key":"BF02247441_CR64","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1476-5381.1991.tb12413.x","volume":"104","author":"L Singh","year":"1991","unstructured":"Singh L, Field MJ, Hughes J, Menzies R, Oles RJ, Vass CA, Woodruff GN (1991a) The behavioral properties of CI-988, a selective cholecystokinin(B) receptor antagonist. Br J Pharmacol 104:239\u2013245","journal-title":"Br J Pharmacol"},{"key":"BF02247441_CR65","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1073\/pnas.88.4.1130","volume":"88","author":"L Singh","year":"1991","unstructured":"Singh L, Lewis AS, Field MJ, Hughes J, Woodruff GN (1991b) Evidence for an involvement of the brain cholecystokinin-B receptor in anxiety. Proc Natl Acad Sci USA 88:1130\u20131133","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02247441_CR66","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0091-3057(93)90492-C","volume":"44","author":"D Treit","year":"1993","unstructured":"Treit D, Menard J, Royan C (1993) Anxiogenic stimuli in the elevated plus-maze. Pharmacol Biochem Behav 44:463\u2013469","journal-title":"Pharmacol Biochem Behav"},{"key":"BF02247441_CR67","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/257604a0","volume":"257","author":"JJ Vanderhaegen","year":"1975","unstructured":"Vanderhaegen JJ, Signeau JC, Gepts W (1975) New peptide in the vertebrate CNS reacting with antigastrin antibodies. Nature 257:604\u2013605","journal-title":"Nature"},{"key":"BF02247441_CR68","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/BF02249335","volume":"114","author":"HJGM Megen Van","year":"1994","unstructured":"Van Megen HJGM, Westenberg HGM, Denboer JA, Haigh JRM, Traub M (1994) Pentagastrin induced panic attacks \u2014 enhanced sensitivity in panic disorder patients. Psychopharmacology 114:449\u2013455","journal-title":"Psychopharmacology"},{"key":"BF02247441_CR69","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/BF00168543","volume":"348","author":"E Vasar","year":"1993","unstructured":"Vasar E, Peuranen E, Harro J, Lang A, Oreland L, Mannisto PT (1993a) Social-isolation of rats increases the density of cholecystokinin receptors in the frontal-cortex and abolishes the antiexploratory effect of cerulein. Naunyn-Schmiedeberg's Arch Pharmacol 348:96\u2013101","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"BF02247441_CR70","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF02246976","volume":"110","author":"E Vasar","year":"1993","unstructured":"Vasar E, Peuranen E, Oopik T, Harro J, Mannisto PT (1993b) Ondansetron, an antagonist of 5-HT3-receptors, antagonizes the antiexploratory effect of cerulein, an agonist of CCK-receptors, in the elevated plus-maze. Psychopharmacology 110:213\u2013218","journal-title":"Psychopharmacology"},{"key":"BF02247441_CR71","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0028-3908(94)90112-0","volume":"33","author":"E Vasar","year":"1994","unstructured":"Vasar E, Lang A, Harro J, Bourin M, Bradwejn J (1994) Evidence for potentiation by CCK antagonists of the effect of cholecystokinin-octapeptide in the elevated plus-maze. Neuropharmacology 33:729\u2013735","journal-title":"Neuropharmacology"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02247441.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02247441\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02247441","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T20:14:09Z","timestamp":1706732049000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02247441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,4]]},"references-count":71,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1996,4]]}},"alternative-id":["BF02247441"],"URL":"https:\/\/doi.org\/10.1007\/bf02247441","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,4]]}}}